Luc Girard

24.6k total citations · 1 hit paper
168 papers, 12.2k citations indexed

About

Luc Girard is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Luc Girard has authored 168 papers receiving a total of 12.2k indexed citations (citations by other indexed papers that have themselves been cited), including 115 papers in Molecular Biology, 72 papers in Oncology and 39 papers in Cancer Research. Recurrent topics in Luc Girard's work include Lung Cancer Treatments and Mutations (29 papers), RNA modifications and cancer (27 papers) and Lung Cancer Research Studies (21 papers). Luc Girard is often cited by papers focused on Lung Cancer Treatments and Mutations (29 papers), RNA modifications and cancer (27 papers) and Lung Cancer Research Studies (21 papers). Luc Girard collaborates with scholars based in United States, Japan and China. Luc Girard's co-authors include John D. Minna, Adi F. Gazdar, Ignacio I. Wistuba, Yang Xie, Michael Peyton, Carmen Behrens, Wan L. Lam, Jonathan R. Pollack, Mitsuo Sato and Pei Wang and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Luc Girard

165 papers receiving 12.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular Profiling of Breast Cancer Cell Lines Defines Relevant Tumor Models and Provides a Resource for Cancer Gene Discovery

2009 611 citations Luc Girard, Adi F. Gazdar et al. profile →

Peers

Luc Girard

ONCOL

PRM

GENET

Jann N. Sarkaria United States

Yoshitaka Sekido Japan

Hui‐Kuan Lin United States

Takashi Kohno Japan

John W.M. Martens Netherlands

Yataro Daigo Japan

Dean G. Tang United States

Somasekar Seshagiri United States

James Brugarolas United States

Roderick L. Beijersbergen Netherlands

Jann N. Sarkaria United States

Luc Girard

9.5k ×1.2

5.4k ×1.2

ONCOL

3.5k ×1.2

2.1k ×0.7

PRM

895 ×0.7

GENET

Citations per year, relative to Luc Girard Luc Girard (= 1×) peers Jann N. Sarkaria

Countries citing papers authored by Luc Girard

Since Specialization

Citations

This map shows the geographic impact of Luc Girard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luc Girard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luc Girard more than expected).

Fields of papers citing papers by Luc Girard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luc Girard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luc Girard. The network helps show where Luc Girard may publish in the future.

Co-authorship network of co-authors of Luc Girard

This figure shows the co-authorship network connecting the top 25 collaborators of Luc Girard. A scholar is included among the top collaborators of Luc Girard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luc Girard. Luc Girard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yan, Xiang, Xiaoshan Zhang, Li Wang, et al.. (2018). Inhibition of Thioredoxin/Thioredoxin Reductase Induces Synthetic Lethality in Lung Cancers with Compromised Glutathione Homeostasis. Cancer Research. 79(1). 125–132. 62 indexed citations

Motea, Edward A., Farjana Fattah, Ling Xiao, et al.. (2018). Kub5-Hera RPRD1B Deficiency Promotes “BRCAness” and Vulnerability to PARP Inhibition in BRCA-proficient Breast Cancers. Clinical Cancer Research. 24(24). 6459–6470. 12 indexed citations

Kasiri, Sahba, Baozhi Chen, Paul Yenerall, et al.. (2017). GLI1 Blockade Potentiates the Antitumor Activity of PI3K Antagonists in Lung Squamous Cell Carcinoma. Cancer Research. 77(16). 4448–4459. 26 indexed citations

Zhou, Xiaorong, Barrett L. Updegraff, Yabin Guo, et al.. (2016). PROTOCADHERIN 7 Acts through SET and PP2A to Potentiate MAPK Signaling by EGFR and KRAS during Lung Tumorigenesis. Cancer Research. 77(1). 187–197. 56 indexed citations

Tian, Hui, Jui-Yun Lu, Kenneth E. Huffman, et al.. (2015). Systematic siRNA Screen Unmasks NSCLC Growth Dependence by Palmitoyltransferase DHHC5. Molecular Cancer Research. 13(4). 784–794. 37 indexed citations

Delgado, Oliver, Kimberly Batten, James A. Richardson, et al.. (2014). Radiation-Enhanced Lung Cancer Progression in a Transgenic Mouse Model of Lung Cancer Is Predictive of Outcomes in Human Lung and Breast Cancer. Clinical Cancer Research. 20(6). 1610–1622. 23 indexed citations

Schuster, Katja, Niranjan Venkateswaran, Andrea Rabellino, et al.. (2014). Nullifying the CDKN2AB Locus Promotes Mutant K-ras Lung Tumorigenesis. Molecular Cancer Research. 12(6). 912–923. 31 indexed citations

Taguchi, Ayumu, Allen D. Taylor, Jaime Rodriguez‐Canales, et al.. (2014). A Search for Novel Cancer/Testis Antigens in Lung Cancer Identifies VCX/Y Genes, Expanding the Repertoire of Potential Immunotherapeutic Targets. Cancer Research. 74(17). 4694–4705. 36 indexed citations

Riquelme, Erick, Milind Suraokar, Carmen Behrens, et al.. (2014). VEGF/VEGFR-2 Upregulates EZH2 Expression in Lung Adenocarcinoma Cells and EZH2 Depletion Enhances the Response to Platinum-Based and VEGFR-2–Targeted Therapy. Clinical Cancer Research. 20(14). 3849–3861. 59 indexed citations

10.

Sullivan, James P., Luc Girard, Alexander Augustyn, et al.. (2014). Essential Role of Aldehyde Dehydrogenase 1A3 for the Maintenance of Non–Small Cell Lung Cancer Stem Cells Is Associated with the STAT3 Pathway. Clinical Cancer Research. 20(15). 4154–4166. 135 indexed citations

11.

Rabellino, Andrea, Brandon Carter, Georgia Konstantinidou, et al.. (2012). The SUMO E3-ligase PIAS1 Regulates the Tumor Suppressor PML and Its Oncogenic Counterpart PML-RARA. Cancer Research. 72(9). 2275–2284. 94 indexed citations

12.

Saintigny, Pierre, Shaohua Peng, Li Zhang, et al.. (2012). Global Evaluation of Eph Receptors and Ephrins in Lung Adenocarcinomas Identifies EphA4 as an Inhibitor of Cell Migration and Invasion. Molecular Cancer Therapeutics. 11(9). 2021–2032. 48 indexed citations

13.

Xie, Yang, Guanghua Xiao, Kevin R. Coombes, et al.. (2011). Robust Gene Expression Signature from Formalin-Fixed Paraffin-Embedded Samples Predicts Prognosis of Non–Small-Cell Lung Cancer Patients. Clinical Cancer Research. 17(17). 5705–5714. 130 indexed citations

14.

Sunaga, Noriaki, David S. Shames, Luc Girard, et al.. (2011). Knockdown of Oncogenic KRAS in Non–Small Cell Lung Cancers Suppresses Tumor Growth and Sensitizes Tumor Cells to Targeted Therapy. Molecular Cancer Therapeutics. 10(2). 336–346. 135 indexed citations

15.

Yang, Fei, Ximing Tang, Erick Riquelme, et al.. (2011). Increased VEGFR-2 Gene Copy Is Associated with Chemoresistance and Shorter Survival in Patients with Non–Small-Cell Lung Carcinoma Who Receive Adjuvant Chemotherapy. Cancer Research. 71(16). 5512–5521. 51 indexed citations

16.

Dai, Bingbing, Jieru Meng, Michael Peyton, et al.. (2011). STAT3 Mediates Resistance to MEK Inhibitor through MicroRNA miR-17. Cancer Research. 71(10). 3658–3668. 80 indexed citations

17.

Cai, Di, David S. Shames, Maria Gabriela Raso, et al.. (2010). Steroid Receptor Coactivator-3 Expression in Lung Cancer and Its Role in the Regulation of Cancer Cell Survival and Proliferation. Cancer Research. 70(16). 6477–6485. 48 indexed citations

18.

Shivapurkar, Narayan, Victor Stastny, Naoki Okumura, et al.. (2008). Cytoglobin, the Newest Member of the Globin Family, Functions as a Tumor Suppressor Gene. Cancer Research. 68(18). 7448–7456. 91 indexed citations

19.

Das, Amit Kumar, Mitsuo Sato, Michael D. Story, et al.. (2006). Non–Small Cell Lung Cancers with Kinase Domain Mutations in the Epidermal Growth Factor Receptor Are Sensitive to Ionizing Radiation. Cancer Research. 66(19). 9601–9608. 178 indexed citations

20.

Zhao, Xiaojun, Barbara A. Weir, Thomas LaFramboise, et al.. (2005). Homozygous Deletions and Chromosome Amplifications in Human Lung Carcinomas Revealed by Single Nucleotide Polymorphism Array Analysis. Cancer Research. 65(13). 5561–5570. 242 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact